This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
Journal of Experimental & Clinical Cancer Research Open Access 14 October 2022
-
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
BMC Neuroscience Open Access 17 October 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Phase 3 data for PCSK9 inhibitor wows. Nat Biotechnol 31, 1057–1058 (2013). https://doi.org/10.1038/nbt1213-1057
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1213-1057
This article is cited by
-
PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
Journal of Experimental & Clinical Cancer Research (2022)
-
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
BMC Neuroscience (2018)
-
Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease
Nature Genetics (2015)
-
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs
Drugs (2015)
-
Amgen and Regeneron push for a genetic renaissance in drug discovery
Nature Biotechnology (2014)